1-8 of 8
Ryohei Tanizaki
Close
Sort by
Journal Articles

Treatment with mTOR Inhibitor, Everolimus (RAD001) Overcomes Resistance to Imatinib In Ph-Leukemia Quiescent Cells.

Yachiyo Kuwatsuka, MD, Yosuke Minami, MD, PhD, Miho Minami, Ryohei Tanizaki, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1579.
https://doi.org/10.1182/blood.V116.21.1579.1579
Published: 2010
Journal Articles

Treatment with mTOR Inhibitor, Everolimus (RAD001) Overcomes Resistance to Imatinib in Ph-Leukemia Quiescent or T315I-Mutated Cells.

Yosuke Minami, MD, PhD, Miho Minami, Yachiyo Kuwatsuka, MD, Ryohei Tanizaki, MS, Yuka Nomura, Akihiro Abe, MD, PhD, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3277.
https://doi.org/10.1182/blood.V114.22.3277.3277
Published: 2009
Journal Articles

Treatment with Bortezomib Overcomes Resistance to Imatinib in Ph-Leukemia Quiescent Cells.

Yachiyo Kuwatsuka, MD, Yosuke Minami, MD, PhD, Ryohei Tanizaki, MS, Miho Minami, Akihiro Abe, MD, PhD, Yuka Nomura, Hitoshi Kiyoi, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1426.
https://doi.org/10.1182/blood.V114.22.1426.1426
Published: 2009
Journal Articles

KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation

Yukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa, Ryohei Tanizaki, Makiko Shimizu, Hiroshi Umehara, Kenichi Ishii, Yumiko Mori, Kazutaka Ozeki, Yosuke Minami, Akihiro Abe, Hiroshi Maeda, Tadakazu Akiyama, Yutaka Kanda, Yuko Sato, Shiro Akinaga, Tomoki Naoe
Journal: Blood
Blood (2009) 114 (8): 1607–1617.
https://doi.org/10.1182/blood-2009-01-199307
Published: 2009
Journal Articles

Prognostic Implication and Biological Roles of RhoH in Acute Myeloid Leukemia.

Akira Katsumi, MD, PhD, Toshihiro Iwasaki, MD, PhD, Ryohei Tanizaki, MS, Akihiro Abe, MD, PhD, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 939.
https://doi.org/10.1182/blood.V112.11.939.939
Published: 2008
Journal Articles

KW-2449, a Novel Multi-Kinase Inhibitor, Suppresses the Growth of Imatinib-Resistant Ph+ Leukemia Including BCR-ABL/T315I Both in Vitro and in Vivo.

Yukimasa Shiotsu, PhD, Hitoshi Kiyoi, MD, PhD, Ryohei Tanizaki, MD, PhD, Yosuke Minami, MD, PhD, Akihiro Abe, MD, PhD, Yuichi Ishikawa, MD, PhD, Kenichi Ishii, Makiko Shimizu, Yutaka Kanda, PhD, Yuko Sato, MD, PhD, Shiro Akinaga, PhD, Jorge Cortes, MD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1640.
https://doi.org/10.1182/blood.V112.11.1640.1640
Published: 2008
Journal Articles

Treatment with Hsp90 Inhibitor, 17-AAG Overcomes Resistance to Small Molecule FLT3-Inhibitors in FLT3/ITD-Positive Leukemia Cells Harboring N676K-Mutation.

Yosuke Minami, MD, PhD, Yuka Nomura, Akihiro Abe, MD, PhD, Ryohei Tanizaki, MS, Yachiyo Kuwatsuka, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD
Journal: Blood
Blood (2008) 112 (11): 1619.
https://doi.org/10.1182/blood.V112.11.1619.1619
Published: 2008
Journal Articles

Prognostic Implications and Biological Roles of RhoH in Acute Myeloid Leukemia.

Toshihiro Iwasaki, MD, Akira Katsumi, M.D., Ph.D., Hitoshi Kiyoi, M.D., Ph.D., Ryohei Tanizaki, Miki Kobayashi, M.D., Ph.D., Akihiro Abe, M.D., Ph.D., Tadashi Matsushita, M.D., Ph.D., Tomoki Naoe, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 4246.
https://doi.org/10.1182/blood.V110.11.4246.4246
Published: 2007